News

Bristol-Myers Squibb: Great Dividend But Questionable Growth Prospects
Bristol-Myers Squibb faces revenue declines but offers long-term potential via growth drugs. Read what BMY stock has to offer ...
TJX Companies: Q1 Earnings Confirm Profitability And Growth, Yet Shares Remain Expensive
TJX's off-price model drives growth amid challenges. International expansion is showing improving profitability. Read an ...
Vulcan Materials: Shares Are Still Too Pricey For My Liking
Recent asset sales and acquisitions have reshaped Vulcan Materials' business. Check out my fresh take on VMC stock here.
Elbit Systems: Record Backlog, But Political Risk Still Looms
Elbit Systems' Q1 numbers were strong across the board. Click here to read more about ESLT stock's catalysts, risks, ...
Alimentation Couche-Tard: Hold Until The Macro Situation Turns For The Better
Alimentation Couche-Tard is rated Hold amid US macro headwinds, rising costs, and near-term challenges affecting earnings ...
Abercrombie & Fitch: Two Steps Forward, Two Steps Back
Abercrombie & Fitch's Hollister delivered record results, but Abercrombie brand demand sharply deteriorated. Learn more about ...
Renault to take $11 billion charge over revised accounting of Nissan stake
Renault Group (RNSDF) on Tuesday said it would record a €9.5 billion ($11.2 billion) non-cash loss in the first half of the year due to changes in how it accounts for its stake in Nissan (NSANY).